Zdeblick T A, Field G A, Shaffer J W
Department of Orthopaedic Surgery, Case Western Reserve University School of Medicine, Cleveland, Ohio.
J Hand Surg Am. 1988 Nov;13(6):948-53. doi: 10.1016/0363-5023(88)90278-x.
An experimental model of frostbite using a standard cold injury in rats was used to test the therapeutic usefulness of the fibrinolytic agent urokinase. Control groups included rapid rewarming, slow rewarming, and slow rewarming followed by saline infusion. Urokinase was administered through an intra-arterial catheter 30 minutes after cold injury and slow rewarming. Optimum results were obtained with rapid rewarming of the extremity at 43 degrees C. However, with rewarming at room temperature eventual tissue loss was significantly decreased with the infusion of urokinase compared with either no treatment or saline infusion. In the clinical situation where the patient with frostbite is seen after slow rewarming, we believe that clinical trials of the use of a fibrinolytic agent are warranted.
使用大鼠标准冷损伤的冻伤实验模型来测试纤溶药物尿激酶的治疗效果。对照组包括快速复温、缓慢复温和缓慢复温后输注生理盐水。冷损伤和缓慢复温30分钟后,通过动脉内导管给予尿激酶。在43摄氏度对肢体进行快速复温可获得最佳结果。然而,在室温下复温时,与不治疗或输注生理盐水相比,输注尿激酶可显著减少最终的组织损失。在缓慢复温后见到冻伤患者的临床情况下,我们认为有必要对使用纤溶药物进行临床试验。